MAP2K7 and non-small cell lung carcinoma: V-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation is one of oncogenic driver mutation in NSCLC, which phosphorylates the downstream effectors MEK and ERK to promote cell proliferation and survival (2).